Cape Coral
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
11- Dermatology
- 10
- Plastic Surgery
- 1
Confirming physician supervision before account approval
Because medspas vary in how directly a physician is involved day to day, Precision Biologics verifies that each account is tied to a licensed physician or operates under documented physician supervision, in addition to requiring a National Provider Identifier. This step is separate from, and does not replace, any state licensing or medical-director requirement that already applies to the practice.
What aesthetic practices typically request before purchasing
Dermatology and medspa accounts generally ask for the same documentation as other specialties: lot-specific certificates of analysis, donor eligibility summaries and sterility testing results. For exosome products, full ingredient disclosures and supplier characterization data are also available to verified accounts, since these formulations include added components beyond the base exosome preparation.
- Certificate of analysis by lot
- Full ingredient disclosure for exosome products
- Donor eligibility and sterility testing summaries
Receiving shelf-stable and cold-chain shipments
Several exosome formats are shelf-stable and do not require refrigeration under normal storage conditions, while Wharton's jelly formats generally ship cryopreserved on dry ice. Practices that stock both categories should set up separate receiving procedures for each rather than assuming a single intake process covers everything.
Verifying regulatory status with your board and counsel
Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, and FDA has stated there are no FDA-approved exosome products. Whether a Wharton's jelly product's intended use fits the applicable HCT/P framework is a separate determination for the practice and its counsel. Florida practices should also confirm current requirements with the Florida Board of Medicine; Florida's SB 1768 addresses certain non-FDA-approved stem cell therapies in orthopedics, wound care and pain management specifically, so its relevance to aesthetic use should be confirmed with counsel rather than assumed.
These products are not FDA approved or licensed for any disease or condition.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Can a medspa without a physician on staff open an account?+
Accounts require a verified National Provider Identifier and confirmation of physician supervision. A medspa should be prepared to document how a licensed physician oversees the practice.
Are exosome products the same regulatory category as Wharton's jelly products?+
No. Exosome products are generally regulated as biologic drugs under section 351; Wharton's jelly products are offered under the supplier's HCT/P framework, and whether a given use qualifies under 21 CFR 1271.10 is a determination for the practice and its counsel.
Can our practice get the full ingredient list for exosome products before ordering?+
Yes. Full ingredient disclosures are provided to verified accounts on request.